MedTech Venture Builder Collaborative Centre of Excellence
The LIHE MedTech Venture Builder (MVB), now in its third year, is a 12-month structured programme in two stages to speed-up the commercial and clinical translation of promising medical technologies into robust, investment-ready healthcare ventures.
Supporting companies from across the UK, the MVB, the first of its kind, is a collaborative effort led by LIHE, in collaboration with leading NHS Trusts, industrial partners, prominent charities, and select impact investors.
Our collaborative focus on MedTech allows us to take ventures a significant step further than what has been achieved before programmatically. Understanding how to execute in this highly regulated and evidence-driven environment is key to attracting further dilutive and non-dilutive investment.
We provide the structures that are critical to de-risking your company for such investment, such as a clinical evidence roadmap and stakeholder mapping, a regulatory plan, extensive hands-on guidance and monthly strategic progress review, all while aligning with the requirements of a Quality Management System (QMS).
This is a truly unique opportunity for very select, high-potential MedTech companies from across the UK to receive fully customised, extensive executive support from experts in commercial and clinical translation from the partners.
The MVB was created with the support of a significant grant by Research England for a Collaborative Centre of Excellence (CCoE) for MedTech translation. The programme is further supported by our strategic partners, Team Consulting.
